IL6 and pulmonary arterial hypertension: IL-6 levels are independently associated with RV dysfunction in patients with PAH (88), and increased plasma levels of plasma CXC-chemokine ligand (CXCL) 10, CXCL12, and CXCL16 are associated with RV dysfunction in patients with IPAH (89).